Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-23

Clinical Trial Update: Gabapentin for the Treatment of Hot Flashes in Menopausal Women [Phase 3]

View source ↗

Summary

Gabapentin was studied in a Phase 3 trial to treat hot flashes in menopausal women. The study status is completed, but no results are provided in this snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEURONTIN (gabapentin)

Snippet

Sponsor: North Toronto Primary Care Research Network | Conditions: Hot Flashes, Menopause | Phase 3 | Status: COMPLETED